InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Sands Capital Ventures Discovery Fund III, L.P.. Director active across 1 company, notably Acumen Pharmaceuticals, Inc.. Aggregated, 2 filings have been published. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations